Novartis AG - Price To Sales Ratio

Novartis AG's Fiscal Year is From January To December.

The item "Price-To-Sales-Ratio" stands at 4.27 as of 09/30/2025.

As of the end of Novartis AG's third quarter, the item "Price To Sales Ratio" stands at 4.27. This represents a decrease of -0.1 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -4.02 percent compared to the value the year prior.
The 1 year change in percent is -4.02.
The 3 year change in percent is 70.18.

The Serie's long term average value is 3.62. It's latest available value, on 09/30/2025, is 18.02 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is +70.18%.
The Serie's change in percent from it's maximum value, on 09/30/2024, to it's latest available value, on 09/30/2025, is -4.02%.